Low frequency mutations have been identified in ARID1A/B, ATRX, LIN28B and TP53, as well as genes in the MAPK and Rho-Rac signalling pathways, especially in relapsed neuroblastoma [20,21]. Here, ATRX is linked to neuroblastoma.